CONNECT WITH US
Social Media

Social Media

From DC, VisionQuest to Aasha: Best OTT Release this Week

TelecomTalk - OTT logo

Published on

Add as a preferred source on Google
From DC, VisionQuest to Aasha: Best OTT Release this Week

The weekend is here, and we’ve got you covered with some of the latest OTT releases in Hindi, Tamil, Malayalam, and English, including Marvel Cinematic Universe’s VisionQuest. In Hindi, we have the true-story-based Jeet Ki Zid, which revolves around the Kargil War and stars Mirnal Kulkarni and Ami. For the best South Indian OTT releases, you can enjoy the blockbuster hit DC in Tamil, starring Tollywood director and writer Lokesh Kanagaraj and Hollywood star Wamiqa Gabbi. Other Tamil movies include Enna Vilai, starring Nimisha Sajayan, Deep Shankar, Motta Rajendran, Karunas, Chethan Cheenu, and Chiththa Darshan.

Other OTT releases include Sangeeth Prathap’s new movie, It’s A Medical Miracle, which is also now on OTT. Joju George and Urvashi’s Aasha will also arrive on OTT this week.

Here are some of the best OTT releases this week. You can watch these movies and shows on prominent streaming platforms like Zee5, JioHotstar, Netflix, SonyLIV, and ManoramaMax, which is dropping new movies and TV shows this week.

Starting with the new MCU (Marvel Cinematic Universe) web series, Paul Bettany returns as Vision in VisionQuest, which will stream on JioHotstar. VisionQuest will follow Vision as he faces challenges while trying to regain his memory.

If you’re looking for the best Tamil OTT movie, check out the new Lokesh Kanagaraj and Wamiqa Gabbi DC, which grossed a whopping Rs 110 crore worldwide on a Rs 25 crore budget.

The movie’s plot follows a rebellious character, Devdas (Lokesh), and Chanda (Wamiqa Gabbi), who enter and survive in a dangerous world of rage and bloodshed.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.